Eccrine squamous syringometaplasia from chemotherapy extravasation;Siringometaplasia escamosa ecrina por extravasación de quimioterapia

Actas Dermo-Sifiliograficas

Volumn 96, Issue 7, 2005, Pages 462-464

  Bordel, Ma Teresa ^a,b   Miranda, Alberto ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b NONE   (Spain)

Author keywords

Chemotherapy; Eccrine squamous syringometaplasia; Extravasation

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DERMATITIS; DISEASE ASSOCIATION; ECCRINE SQUAMOUS SYRINGOMETAPLASIA; EPIDERMIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG CARCINOMA; MALE; METAPLASIA; PHYSICAL EXAMINATION; RARE DISEASE; SKIN TUMOR; TISSUE NECROSIS; ULCER;

EID: 27244458966     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(05)73113-6     Document Type: Article

References (19)

1. Hurt MA, Halvorson RD, Petr FC Jr, Cooper JT Jr, Friedman DJ. Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of «chemotherapy-associated eccrine hidradenitis» and «neutrophilic eccrine hidradenitis». Arch Dermatol. 1990;126:73-7.
2. Doll D, Yarbo J. Vascular toxicity associated with antineoplastic agents. Semin Oncol. 1992;19:580-96.
3. Scuderi N, Onesti M. Antitumor agents: extravasation managements, and surgical treatment. Ann Plast Surg. 1994;32:39-44.
4. King DT, Barr RJ. Syringometaplasia: mucinous and squamous variants. J Cutan Pathol. 1979;6:284-91.
5. Cornil V. Contributions a l'histoire du dévelopment histologique des tumeurs épithéliales. J L'Anat Physiol. 1865;2:476.
6. Mehregan AH. Proliferation of sweat ducts in certain diseases of the skin. Am J Dermatopathol. 1981;3:27-31.
7. Muñoz E, Valks R, Fernández-Herrera J, Fraga J. Herpetic syringitis associated with eccrine squamous syringometaplasia in HIV-positive patients. J Cutan Pathol. 1997;24:425-8.
8. Metcalf JS, Maize JC. Squamous syringometaplasia in lobular panniculitis and pyoderma gangrenosum. Am J Dermatopathol. 1990;12:141-9.
9. Helton JL, Metcalf JS. Squamous syringometaplasia in association with annular elastolytic granuloma. Am J Dermatopathol. 1995;17:407-9.
10. Lerner TH, Barr RJ, Dolezal JF, Stagnone JJ. Syringomatous hyperplasia and eccrine squamous syringometaplasia associated with benoxaprofen therapy. Arch Dermatol. 1987;123:1202-4.
11. Caputo R, Monti M, Ermarcora E, et al. Cutaneous manifestations of tetrachlorodibenzeno-p-dioxin in children and adolescents. J Am Acad Dermatol. 1988;19:812-9.
12. Vargas-Díez E, Valks R, Fraga J, Fernández-Herrera J, García-Díez A. Eccrine squamous syringometaplasia in a patient with phytophotodermatosis. Int J Dermatol. 1998;37:715-7.
13. Serrano T, Sáez A, Moreno A. Eccrine squamous syringometaplasia. A prospective clinicopathologic study. J Cutan Pathol. 1993;20:61-5.
14. Jerasutus S, Laohabha K, Suvanprakorn P. Primary squamous siringometaplasia with no underlying malignancy. Int J Dermatol. 1999;38:375-6.
15. Romero-Gómez J, Vera Casaño A, Sanz Frelles A, Acha García T, Martínez García S, Crespo Erchiga V. Siringometaplasia escamosa ecrina como expresión del fenómeno de evocación. Actas Dermosifiliogr. 2002;93:577-80.
16. Cerro M, Torrelo A, Madero L, Mediero I, Zambrano A. Siringometaplasia escamosa ecrina en una niña tratada con quimioterapia. Actas Dermosifiliogr. 2000;91:34-6.
17. Jonson HL, Maibach HL. Drug excretion in human eccrine sweat. J Invest Dermatol. 1971;56:182-8.
18. Horn TD, Beveridge RA, Egorin MJ, Abeloff MD, Hood AF. Observations and proposed mechanism of N,N′,N″-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentation. Arch Dermatol. 1989;125:524-7.
19. Bhawan J, PetryJ, Ryback ME. Histologic changes induced in skin by extravasation of doxorrubicin (adriamycin). J Cutan Pathol. 1989;16:158-63.